EULAR 2025 highlights… EULAR 2025 Highlights- Rheumatoid Arthritis: Clinical (therapeutic) 18 Jul 2025 Cancer Risk in Patients with Rheumatoid Arthritis Receiving Biologic and Targeted Synthetic Disease Modifying Antirheumatic Drugs: Data from a Multicenter National Real-World Registry Abstract format and assignment number: Oral presentation…
ACR Highlights… ACR Convergence 2024 Highlights- Rheumatoid Arthritis: Clinical (therapeutic) 19 Dec 202419 Dec 2024 Efficacy, Safety, Pharmacokinetics of Anti-CD40 Antibody Abiprubart in Patients with Rheumatoid Arthritis: A Phase 2, Randomized, Placebo-Controlled 12-week-treatment Proof-of-Concept Study Abstract format and assignment number: Oral presentation 1678 Presenting author:…
ACR Congress Do Not Miss… ACR Convergence 2024: Do Not Miss – Rheumatoid arthritis II – Clinical (therapeutic) 5 Nov 20246 Nov 2024 Piotr Kuszmiersz MD PhDPiotr has a PhD in Medical Sciences and is an internal medicine specialist, currently undertaking his rheumatology training at the Department of Rheumatology and Immunology, Jagiellonian University…
ACR Highlights… ACR Convergence Highlights 2023 – Rheumatoid Arthritis: Clinical (therapeutic) 9 Dec 20239 Dec 2023 Author: Victoria Konzett Cope et al. (0835) investigated the efficacy of T-cell co-stimulation with Abatacept on prevention of disease onset in an autoantibody-positive population with arthralgia at risk of developing RA,…